Because disruption of IFN-γ signaling causes abnormal responses to BCG,46–48 and three CCR2-deficient patients (P1, P3, and P9) developed lymphadenitis or disseminated BCG disease following BCG vaccination, we evaluated IFN-γ-mediated immunity (Table S1). The gene discussed is IFNG; the disease is lymphadenitis.